BENUSSI, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 4.378
EU - Europa 1.692
AS - Asia 792
SA - Sud America 9
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 2
Totale 6.885
Nazione #
US - Stati Uniti d'America 4.369
CN - Cina 503
IT - Italia 415
UA - Ucraina 348
DE - Germania 284
HK - Hong Kong 237
GB - Regno Unito 171
FI - Finlandia 149
IE - Irlanda 123
FR - Francia 73
RU - Federazione Russa 38
BE - Belgio 36
IN - India 17
PL - Polonia 16
SE - Svezia 14
TR - Turchia 13
AU - Australia 8
BR - Brasile 8
CA - Canada 8
NL - Olanda 8
TW - Taiwan 6
ES - Italia 5
EU - Europa 4
IR - Iran 4
DK - Danimarca 3
JP - Giappone 3
SG - Singapore 3
AT - Austria 2
GR - Grecia 2
RO - Romania 2
SA - Arabia Saudita 2
VN - Vietnam 2
AL - Albania 1
AZ - Azerbaigian 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
ID - Indonesia 1
MU - Mauritius 1
NO - Norvegia 1
PT - Portogallo 1
SL - Sierra Leone 1
Totale 6.885
Città #
Fairfield 698
Woodbridge 384
Ashburn 332
Chandler 318
Jacksonville 294
Wilmington 252
Cambridge 247
Seattle 246
Houston 237
Hong Kong 234
Ann Arbor 226
Princeton 200
New York 197
Helsinki 141
Dublin 123
Beijing 108
Nanjing 81
Brescia 75
Dearborn 75
Milan 62
Shanghai 42
Brussels 36
Des Moines 36
Jinan 35
Nanchang 35
San Diego 35
Hebei 33
Shenyang 28
Changsha 26
London 22
Lancaster 19
Los Angeles 19
Norwalk 15
San Mateo 15
Warsaw 15
Rome 14
San Francisco 14
Ningbo 13
Augusta 12
Taizhou 12
Jiaxing 11
Kocaeli 11
Kunming 11
Hangzhou 10
Guangzhou 9
Torino 8
Trieste 8
Boardman 7
Chiswick 7
Haikou 7
Mumbai 7
Rende 7
Taiyuan 7
Tianjin 7
Washington 7
Bergamo 6
Leawood 6
Taipei 6
Castelli Calepio 5
Honolulu 5
La Loggia 5
Lucca 5
Monmouth Junction 5
Orange 5
San Giuliano Terme 5
São Paulo 5
Toronto 5
Fuzhou 4
Gunzenhausen 4
Iseo 4
Islington 4
Kilburn 4
La Seyne-sur-Mer 4
Nürnberg 4
Parma 4
Redwood City 4
Venezia 4
Verona 4
Zhengzhou 4
Arezzo 3
Avigliana 3
Bienno 3
Cagliari 3
Chicago 3
Cisano Bergamasco 3
Falkenstein 3
Frankfurt am Main 3
Lanzhou 3
Lappeenranta 3
Lodi 3
Mantova 3
Melbourne 3
Prescot 3
Rio Saliceto 3
Valby 3
Wandsworth 3
Barcelona 2
Belluno 2
Bournemouth 2
Cremona 2
Totale 5.300
Nome #
Discrimination of atypical parkinsonisms with transcranial magnetic stimulation 159
Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy 153
Mendelian forms of disease and age at onset affect survival in frontotemporal dementia 143
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 140
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 140
COVID-19 impact on consecutive neurological patients admitted to the emergency department 138
Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy 121
Autoimmunity and frontotemporal dementia 116
Metodo di generazione di un indice diagnostico per malattia di alzheimer, apparato elettronico di implementazione del metodo e sistema 116
Cortico-spinal tDCS in ALS: A randomized, double-blind, sham-controlled trial 115
Response to comments on natural history and predictors of survival in progressive supranuclear palsy 112
Sensitivity and specificity of transcranial magnetic stimulation for differential diagnosis of Alzheimer’s disease and frontotemporal dementia 108
Diagnosing Progressive Supranuclear Palsy: Role of Biological and Neuroimaging Markers 105
Preliminary Results on Long-Term Potentiation-Like Cortical Plasticity and Cholinergic Dysfunction After Miglustat Treatment in Niemann-Pick Disease Type C. 103
Phenotypic heterogeneity of Niemann-Pick disease type C in monozygotic twins. 102
Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia. 101
Long term clinical and neurophysiological effects of cerebellar transcranial direct current stimulation in patients with neurodegenerative ataxia. 101
Cerebellar transcranial direct current stimulation in patients with ataxia: A double-blind, randomized, sham-controlled study. 100
Cerebrospinal fluid tau levels predict prognosis in non-inherited frontotemporal dementia. 100
Clinical and biomarker changes in presymptomatic genetic frontotemporal dementia 97
The impact of transcranial magnetic stimulation on diagnostic confidence in patients with Alzheimer disease 95
Clinical, genetic, and neuroimaging features of Early Onset Alzheimer Disease: the challenges of diagnosis and treatment. 94
Modulating risky decision-making in Parkinson's disease by transcranial direct current stimulation. 94
Multimodal Brain Analysis of Functional Neurological Disorders: A Functional Stroke Mimic Case Series. 93
Natural history and predictors of survival in progressive supranuclear palsy. 92
Method of generation of a diagnostic index for Alzheimer disease, electronic apparatus for implementation of the method and system 92
Enhancing theory of mind in behavioural variant frontotemporal dementia with transcranial direct current stimulation 92
Impaired long-term potentiation-like cortical plasticity in presymptomatic genetic frontotemporal dementia. 91
Facial feedback and autonomic responsiveness reflect impaired emotional processing in Parkinson's Disease. 91
Modulation of long-term potentiation-like cortical plasticity in the healthy brain with low frequency-pulsed electromagnetic fields 90
Mild cognitive impairment in Parkinson's disease is improved by transcranial direct current stimulation combined with physical therapy. 89
Variability and predictors of response to continuous theta burst stimulation: A TMS-EEG study 89
The impact of TMS on the differential diagnosis and progression of dementia 89
Biological, Neuroimaging, and Neurophysiological Markers in Frontotemporal Dementia: Three Faces of the Same Coin. 88
Italian Frontotemporal Dementia Network (FTD Group-SINDEM): sharing clinical and diagnostic procedures in Frontotemporal Dementia in Italy. 87
Neuroanatomical Correlates of Transcranial Magnetic Stimulation in Presymptomatic Granulin Mutation Carriers. 87
Embedded platform-based system for early detection of Alzheimer disease through transcranial magnetic stimulation 86
Toward a Glutamate Hypothesis of Frontotemporal Dementia 86
Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure 82
Author response: Cerebello-spinal tDCS in ataxia: A randomized, double-blind, sham-controlled, crossover trial 80
Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia. 79
Treatment with docosahexaenoic acid in Spinocerebellar Ataxia 38 79
Transcranial Magnetic Stimulation in Alzheimer's Disease and Cortical Dementias 78
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 75
Cerebello-spinal tDCS in ataxia: A randomized, double-blind, sham-controlled, crossover trial 74
CSF p-Tau181/Tau ratio to distinguish FTLD-TDP from FTLD-Tau 73
Recent neuroimaging, neurophysiological, and neuropathological advances for the understanding of NPC 72
Progression of behavioural disturbances in frontotemporal dementia: a longitudinal observational study 71
TMS for staging and predicting functional decline in frontotemporal dementia 71
CSF p-Tau181/Tau ratio as biomarker for TDP pathology in Frontotemporal Dementia 70
Serum neurofilament light in professional soccer players: goal on safety 67
Clinical and neurophysiological characteristics of heterozygous NPC1 carriers 67
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study 66
Cerebello-spinal stimulation in neurodegenerative ataxia: A randomized, double-blind, sham-controlled, crossover trial 65
Transcranial magnetic stimulation and amyloid markers in mild cognitive impairment: Impact on diagnostic confidence and diagnostic accuracy 65
Neurophysiological Correlates of Positive and Negative Symptoms in Frontotemporal Dementia 58
Prevalence of cerebrospinal fluid Alzheimer disease-like pattern in atypical dementias 57
Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study 57
Classification Accuracy of Transcranial Magnetic Stimulation for the Diagnosis of Neurodegenerative Dementias 55
Recent advances in understanding frontotemporal degeneration 53
Altered inhibitory interaction among inferior frontal and motor cortex in l-dopa-induced dyskinesias 50
Cortical Inhibitory Imbalance in Functional Paralysis 50
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses 47
Expanding the role of education in frontotemporal dementia: a functional dynamic connectivity (the chronnectome) study 43
New insights into the genetic etiology of Alzheimer’s disease and related dementias 42
Transcranial stimulation in frontotemporal dementia: A randomized, double-blind, sham-controlled trial 42
Voluntary inhibitory control and impulsivity in Parkinson’s disease patients with and without levodopa-induced dyskinesias 40
Classification accuracy of TMS for the diagnosis of mild cognitive impairment 40
Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia 39
Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration 38
Clinical and radiological features of posterior cortical atrophy (PCA) in a GRN mutation carrier: a case report 34
Alterations of frontal-temporal gray matter volume associate with clinical measures of older adults with COVID-19 34
Effects of COVID-19 outbreak on stroke admissions in Brescia, Lombardy, Italy 33
Diagnostic Accuracy of the Five-Word Test for Mild Cognitive Impairment Due to Alzheimer’s Disease 32
Non-invasive cerebellar stimulation in neurodegenerative ataxia: A literature review 31
MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia 31
Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study 31
Imaging features and ultraearly hematoma growth in intracerebral hemorrhage associated with COVID-19 31
Hierarchical spectral clustering reveals brain size and shape changes in asymptomatic carriers of C9orf72 30
Dissemination in time and space in presymptomatic granulin mutation carriers: a GENFI spatial chronnectome study 30
Clinical outcome of neurological patients with COVID-19: the impact of healthcare organization improvement between waves 30
Exposure to gamma tACS in Alzheimer's disease: A randomized, double-blind, sham-controlled, crossover, pilot study 28
Cognitive composites for genetic frontotemporal dementia: GENFI-Cog 28
Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia 27
Structural brain splitting is a hallmark of Granulin-related frontotemporal dementia 26
Data-driven staging of genetic frontotemporal dementia using multi-modal MRI 26
Impairment of episodic memory in genetic frontotemporal dementia: A genfi study 24
Hyperconnectivity in Dementia Is Early and Focal and Wanes with Progression 24
Neurotransmitter imbalance dysregulates brain dynamic fluidity in frontotemporal degeneration 23
Motor and cognitive outcomes of cerebello-spinal stimulation in neurodegenerative ataxia 23
SARS-CoV-2 infection and acute ischemic stroke in Lombardy, Italy 23
An Automated Toolbox to Predict Single Subject Atrophy in Presymptomatic Granulin Mutation Carriers 23
Serum Glial Fibrillary Acidic Protein (GFAP) Is a Marker of Disease Severity in Frontotemporal Lobar Degeneration 22
The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort 22
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia 21
Aberrant origin of the occipital artery from the internal carotid artery: utility of the occipital tap maneuver 21
Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort 21
Differential early subcortical involvement in genetic FTD within the GENFI cohort 21
Citicoline Treatment in Acute Ischemic Stroke: A Randomized, Single-Blind TMS Study 20
Prodromal frontotemporal dementia: clinical features and predictors of progression 19
Totale 6.729
Categoria #
all - tutte 43.714
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.714


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019311 0 0 0 0 0 0 0 0 0 0 133 178
2019/20201.866 233 93 77 175 116 198 198 192 171 253 82 78
2020/20211.429 54 142 58 116 148 127 66 149 126 204 176 63
2021/2022861 61 71 27 34 10 52 86 82 55 97 100 186
2022/20231.071 121 65 48 71 76 244 24 89 148 55 65 65
2023/2024999 78 32 148 72 37 239 32 55 248 35 23 0
Totale 7.107